Alphatec Holdings, Inc.
ATECHealthcareNASDAQMedical Devices
Scan Results
Daily timeframeAlphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The company carries a $1.19B market cap, placing it firmly in the small-cap category. The company manufactures and sells implants, instruments, imaging equipment, and spare parts.
Market Cap
$1.19B
Beta
0.97
P/E (TTM)
—
P/E (Fwd)
13.42
EPS (TTM)
$-0.83
EPS (Fwd)
$0.58
ROE
—
ROA
-3.8%
Cash
$139.9M
Total Debt
$603.1M
Free CF
$54.6M
52W Change
-37.0%
Annual Financials
Cash vs Debt
The company holds $139.9M in cash, though total debt stands at $603.1M. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. The company generates $54.6M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. Revenue has grown from $243.2M (2021) to $764.2M (2025), reflecting a 214% increase over the period.
Investors considering Alphatec Holdings, Inc. should weigh the typical risks associated with ATEC's sector, size, and financial profile against their own risk tolerance and investment objectives. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Alphatec Holdings, Inc.'s trajectory.